FDA in the process of hiring more than 1k new scientists to speed up drug reviews, according to Bloomberg

FDA in the process of hiring more than 1k new scientists to speed up drug reviews, according to Bloomberg.

The FDA's plan to hire over 1,000 new scientists indicates a significant commitment to accelerating drug reviews, which could streamline the approval process for new pharmaceuticals. This move may enhance investor confidence in biotech and pharmaceuticals, potentially impacting related stocks as well as broader market sentiment surrounding healthcare innovation.